" /> Bevacizumab/Carboplatin/Paclitaxel Regimen - CISMeF





Preferred Label : Bevacizumab/Carboplatin/Paclitaxel Regimen;

NCIt synonyms : Carbo-Taxol-Avastin Regimen; Carboplatin-Paclitaxel-Bevacizumab; Carboplatin/Paclitaxel/Bevacizumab; Carboplatin-Taxol-Bevacizumab; Carboplatin-Taxol-Bevacizumab Regimen;

NCIt related terms : carboplatin-paclitaxel-bevacizumab regimen; Carboplatin and Paclitaxel (CP) and Bevacizumab; Carboplatin and Paclitaxel (CP) and Bevacizumab-maly; Carboplatin and Paclitaxel (CP) and Bevacizumab-bvzr; Carboplatin and Paclitaxel (CP) and Bevacizumab-adcd; Carboplatin and Paclitaxel (CP) and Bevacizumab-onbe; Carboplatin and Paclitaxel (CP) and Bevacizumab-equi; Carboplatin and Paclitaxel (CP) and Bevacizumab-awwb; Carboplatin and Paclitaxel (CP) and Bevacizumab-aybi;

NCIt definition : A regimen consisting of bevacizumab, carboplatin and paclitaxel that can be used in the treatment of endometrial, ovarian, fallopian tube and primary peritoneal, vaginal, vulvar and cervical cancers and non-small cell lung cancer (NSCLC).;

Alternative definition : NCI-GLOSS: A chemotherapy combination used to treat advanced, nonsquamous non-small cell lung cancer. It includes the drugs carboplatin, paclitaxel (Taxol), and bevacizumab.;

NCIt note : Source: NCCN Guidelines 2007;

Codes from synonyms : CDR0000663013; CDR0000663014; 29570; 127609; 127461; 127165; 127387; 127313; 127535; 127239;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
11/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.